Arrowhead Pharma (ARWR)

$20.80 0.34 (1.61%)

16:00 EDT ARWR Stock Quote Delayed 30 Minutes

ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q3 2024

By InvestorPlace Earnings Aug 8, 2024

ARWR stock results show that Arrowhead Pharma missed analyst estimates for earnings per share the third quarter of 2024.

Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025

Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025

ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q2 2024

Volume:

Previous Close -

Market Cap 2.20B

PE Ratio -4.46

EPS -4.66

Volume (Avg. Vol.) 2.05M

Day's Range $20.75 - $21.24

52-Week Range $19.44 - $39.83

Dividend & Yield N/A (N/A)

ARWR Stock Predictions, Articles, and Arrowhead Pharma News

The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024

By Chris Markoch, InvestorPlace Contributor Apr 5, 2024

With risk-on sentiment in place, investors may be looking for the most undervalued Russell 2000 stocks to buy in April.

7 Biotech Stocks to Buy as Sector Rotation Ramps Up

By Josh Enomoto, InvestorPlace Contributor Mar 13, 2024

While the technology sector has been enjoying ridiculous returns, it’s inevitable that a slowdown (or even a correction) may materialize, which brings to the table…

The 3 Most Undervalued Russell 2000 Stocks to Buy in March 2024

By Ian Cooper, InvestorPlace Contributor Mar 11, 2024

The Russell 2000 is up about 4% year to date, and could push higher, taking the most undervalued Russell 2000 stocks along for the ride.

7 Oversold Russell 2000 Stocks to Add to Your February Buy List

By Ian Cooper, InvestorPlace Contributor Feb 25, 2024

Investors may want to jump into oversold Russell 2000 stocks. After a rough outing in 2023, many are starting to come back strong.

7 Biotech Stocks Fighting America’s Deadliest Diseases

By Josh Enomoto, InvestorPlace Contributor Feb 8, 2024

Unlike many other market segments, biotech stocks stand out for their direct relevance. For example, investors who typically wager on aerospace and defense plays usually…

The Best Russell 2000 Stocks to Buy Before they Rebound

By Alex Sirois, InvestorPlace Contributor Feb 15, 2022

Some of the best stocks in the market are among the best Russell 2000 stocks to buy. Here's a list of a few of those choices.

7 Nanotech Stocks To Buy With Huge Returns in Store

By Chris Lau, InvestorPlace Contributor Dec 30, 2020

Seven nanotech stocks to buy have the potential to reward investors as innovation in the sector accelerates.

Arrowhead Pharmaceuticals News: Why ARWR Stock Is Shooting 45% Higher Today

By William White, InvestorPlace Writer Sep 16, 2020

Arrowhead Pharmaceuticals (ARWR) news for Wednesday includes positive interim results from a clinical trial pushing ARWR stock higher.

3 Biotech Stocks to Bank on for Buyouts in 2020

By Aaron Levitt, InvestorPlace Contributor Jan 10, 2020

Flushed with cash, bigger biotech stocks are on the hunt. These 3 smaller drug makers could be the next buyout targets in the new year.

7 Exciting Biotech Stocks to Buy Now

By Louis Navellier, Editor, Growth Investor Dec 2, 2019

Many of these biotech companies are beating the Nasdaq Biotech Index. With cutting-edge therapies, these are great names to buy.

7 Top-Rated Biotech Stocks to Invest In Today

By Louis Navellier, Editor, Growth Investor Jun 14, 2019

Despite the trade dispute with China, these biotech stocks each earn top marks in Portfolio Grader for fundamentals, earnings and momentum.

5 Hot Small-Cap Stocks That Are a Bit Too Toasty

By Josh Enomoto, InvestorPlace Contributor Jan 22, 2019

These small-cap stocks may have triggered your radar, but recently, they have become way too hot to handle.

ARWR Stock Sinks After Signing a Big Collaboration Deal

By Chris Lau, InvestorPlace Contributor Oct 9, 2018

ARWR stock fell big after signing a great collaboration agreement with a JNJ unit. The markets are overreacting.

Arrowhead Stock Is Not Done Rallying After Its 38% Jump

By Chris Lau, InvestorPlace Contributor Sep 7, 2018

Yesterday, Arrowhead's clinical data results excited shareholders, but ARWR stock still has plenty of upside ahead.

3 Stocks to Watch on Wednesday: Arrowhead Pharmaceuticals Inc (ARWR), VeriFone Systems Inc (PAY) and Streamline Health Solutions Inc. (STRM)

By Karl Utermohlen, InvestorPlace Writer Dec 13, 2017

Arrowhead Pharmaceuticals (ARWR), VeriFone Systems (PAY) and Streamline Health Solutions (STRM) posted their earnings results late Tuesday.

Arrowhead Pharma (ARWR)

ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q3 2024

Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025

Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025

ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q2 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Arrowhead Pharma (ARWR)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ARWR Stock Predictions, Articles, and Arrowhead Pharma News

Subscriber Sign in